Commitment COM-201
Post-approval commitment for FDA-2024-0001. Category: Post-Approval Study. Priority: high.
Commitment ID
COM-201
Application
Authority
Food and Drug Administration
Category
Post-Approval Study
Priority
high
Status
Blocked
Due Date
2024-12-11
Completed At
—
Owner
James O'Brien
Created
2023-05-26
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.